1. Home
  2. INTS vs GTIM Comparison

INTS vs GTIM Comparison

Compare INTS & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$4.03

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

Logo Good Times Restaurants Inc.

GTIM

Good Times Restaurants Inc.

HOLD

Current Price

$1.51

Market Cap

15.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTS
GTIM
Founded
2012
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
15.7M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
INTS
GTIM
Price
$4.03
$1.51
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$38.00
N/A
AVG Volume (30 Days)
25.8K
31.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.21
Revenue
N/A
$142,315,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$7.29
Revenue Growth
N/A
3.01
52 Week Low
$0.22
$1.10
52 Week High
$8.06
$2.09

Technical Indicators

Market Signals
Indicator
INTS
GTIM
Relative Strength Index (RSI) 40.32 50.96
Support Level $3.51 $1.44
Resistance Level $5.00 $1.52
Average True Range (ATR) 0.14 0.06
MACD -0.03 -0.00
Stochastic Oscillator 30.08 46.43

Price Performance

Historical Comparison
INTS
GTIM

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants, which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants, which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers, chicken, frozen custard; slides and drinks.

Share on Social Networks: